Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Bio-Techne Cp (TECH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,490,901
  • Shares Outstanding, K 37,873
  • Annual Sales, $ 642,990 K
  • Annual Income, $ 126,150 K
  • 60-Month Beta 1.24
  • Price/Sales 11.65
  • Price/Cash Flow 33.91
  • Price/Book 6.52

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 1.21
  • Number of Estimates 2
  • High Estimate 1.23
  • Low Estimate 1.18
  • Prior Year 1.10
  • Growth Rate Est. (year over year) +10.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
188.45 +4.96%
on 04/25/19
207.84 -4.84%
on 05/06/19
+6.86 (+3.59%)
since 04/24/19
3-Month
180.37 +9.66%
on 04/22/19
207.84 -4.84%
on 05/06/19
+2.82 (+1.45%)
since 02/22/19
52-Week
132.75 +48.99%
on 12/24/18
207.84 -4.84%
on 05/06/19
+46.32 (+30.58%)
since 05/24/18

Most Recent Stories

More News
Bio-Techne To Present At The Jefferies 2019 Global Healthcare Conference

Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Jefferies 2019 Global Healthcare Conference on Wednesday, June 5th, 2019,...

TECH : 197.79 (-0.04%)
Bio-Techne To Present At The UBS Global Healthcare Conference

Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the UBS Global Healthcare Conference on Wednesday, May 22nd, 2019, at 9:00...

TECH : 197.79 (-0.04%)
Roche expands partnership with Bio-Techne to offer drug discovery researchers new chromogenic detection options for mRNA ISH tissue analysis

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced it has expanded its partnership with Bio-Techne by offering drug discovery researchers in the U.S. new chromogenic detection kits for automated in situ...

TECH : 197.79 (-0.04%)
Bio-Techne To Present At The Bank Of America Merrill Lynch 2019 Health Care Conference

Bio-Techne Corporation (NASDAQ:TECH) today announced that Jim Hippel, Chief Financial Officer will present at the Bank of America Merrill Lynch 2019 Health Care Conference on Wednesday, May 15th, 2019,...

TECH : 197.79 (-0.04%)
Bio-Techne Releases Third Quarter Fiscal 2019 Results

Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the third quarter ended March 31, 2019.

TECH : 197.79 (-0.04%)
Bio-Techne Declares Dividend

Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended March 31, 2019. The quarterly dividend will be payable...

TECH : 197.79 (-0.04%)
Earnings Preview: Techne (TECH) Q3 Earnings Expected to Decline

Techne (TECH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TECH : 197.79 (-0.04%)
Elpiscience and Bio-Techne Announce Strategic Collaboration

Elpiscience BioPharma and Bio-Techne Corporation announced today that the companies have entered into a strategic collaboration for the development of anti-cancer therapeutics. Under the terms of the agreement,...

TECH : 197.79 (-0.04%)
Bio-Techne Corp Falls 1.72% on Heavy Volume: Watch For Potential Rebound

Bio-Techne Corp (NASDAQ:TECH) traded in a range yesterday that spanned from a low of $185.48 to a high of $187.49. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of...

TECH : 197.79 (-0.04%)
35.1% Return Seen to Date on SmarTrend Bio-Techne Corp Call (TECH)

SmarTrend identified an Uptrend for Bio-Techne Corp (NASDAQ:TECH) on January 8th, 2019 at $147.26. In approximately 3 months, Bio-Techne Corp has returned 35.06% as of today's recent price of $198.88....

TECH : 197.79 (-0.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More Share

Trade TECH with:

Business Summary

Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising...

See More

Key Turning Points

2nd Resistance Point 202.63
1st Resistance Point 200.21
Last Price 197.79
1st Support Level 196.38
2nd Support Level 194.96

See More

52-Week High 207.84
Last Price 197.79
Fibonacci 61.8% 179.16
Fibonacci 50% 170.29
Fibonacci 38.2% 161.43
52-Week Low 132.75

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar